PubRank

Masahiko Kaito

Author PubWeight™ 47.98‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion. J Hepatol 2008 1.85
2 A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan. J Gastroenterol 2004 1.83
3 Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects. J Gastroenterol Hepatol 2004 1.77
4 Core protein of hepatitis C virus induces cardiomyopathy. Circ Res 2004 1.73
5 Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C. J Gastroenterol Hepatol 2007 1.73
6 Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology 2006 1.60
7 Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C. Mol Med 2007 1.59
8 Current state of Wilson disease patients in central Japan. Intern Med 2010 1.45
9 Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study. Hepatogastroenterology 2002 1.24
10 Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients. Free Radic Biol Med 2006 1.18
11 BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 2007 1.05
12 Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane. J Gastroenterol Hepatol 2006 1.02
13 siRNA-resistance in treated HCV replicon cells is correlated with the development of specific HCV mutations. J Viral Hepat 2006 1.01
14 Efficacy of long-term dietary restriction of total calories, fat, iron, and protein in patients with chronic hepatitis C virus. Nutrition 2004 1.01
15 Accumulation of 8-nitroguanine in the liver of patients with chronic hepatitis C. J Hepatol 2005 1.00
16 Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2007 0.99
17 Polymorphism of UDP-glucuronosyltransferase 1A7 gene: a possible new risk factor for lung cancer. Eur J Cancer 2005 0.92
18 Upregulation of transferrin receptor 2 and ferroportin 1 mRNA in the liver of patients with chronic hepatitis C. J Gastroenterol Hepatol 2005 0.91
19 Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy. Am J Gastroenterol 2008 0.87
20 Evaluation of cingulate gyrus blood flow in patients with liver cirrhosis. Metab Brain Dis 2005 0.87
21 Linkage disequilibrium of UGT1A1 *6 and UGT1A1 *28 in relation to UGT1A6 and UGT1A7 polymorphisms. Oncol Rep 2006 0.86
22 Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice. Am J Physiol Gastrointest Liver Physiol 2002 0.85
23 Circulating level of large splice variants of tenascin-C is a marker of piecemeal necrosis activity in patients with chronic hepatitis C. Liver Int 2006 0.85
24 Nonimmune complexed HCV RNA titer in serum as a predictor of interferon response in patients with chronic hepatitis C. Am J Gastroenterol 2003 0.85
25 Expression of large tenascin-C splice variants by hepatic stellate cells/myofibroblasts in chronic hepatitis C. J Hepatol 2006 0.84
26 Dietary iron restriction improves aminotransferase levels in chronic hepatitis C patients. Hepatogastroenterology 2002 0.84
27 Spirulina-associated hepatotoxicity. Am J Gastroenterol 2002 0.83
28 Lactoferrin inhibits lipid peroxidation in patients with chronic hepatitis C. Hepatol Res 2006 0.83
29 Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C. J Gastroenterol Hepatol 2006 0.83
30 Increased expression of multidrug resistance-associated protein 1 (mrp1) in hepatocyte basolateral membrane and renal tubular epithelia after bile duct ligation in rats. Hepatol Res 2002 0.82
31 Reduction of serum HCV RNA titer by bezafibrate therapy in patients with chronic hepatitis C. Am J Gastroenterol 2004 0.81
32 Molecular mechanism of iron metabolism and overload in chronic hepatitis C. J Gastroenterol 2007 0.81
33 Decreased protein C activation in patients with fulminant hepatic failure. Scand J Gastroenterol 2006 0.81
34 Influence of phlebotomy on iron-related gene expression levels in the livers of patients with chronic hepatitis C. J Gastroenterol 2007 0.81
35 Lactoferrin inhibits hepatitis C virus viremia in chronic hepatitis C patients with high viral loads and HCV genotype 1b. Am J Gastroenterol 2002 0.81
36 Identification of treatment efficacy-related host factors in chronic hepatitis C by ProteinChip serum analysis. Mol Med 2010 0.81
37 Iron reduction therapy by phlebotomy reduces lipid peroxidation and oxidative stress in patients with chronic hepatitis C. J Gastroenterol 2006 0.80
38 Immunization with recombinant Calmette-Guerin bacillus (BCG)-hepatitis C virus (HCV) elicits HCV-specific cytotoxic T lymphocytes in mice. Vaccine 2003 0.80
39 Improvement of regional cerebral blood flow after treatment with branched-chain amino acid solutions in patients with cirrhosis. Eur J Gastroenterol Hepatol 2003 0.79
40 Single photon emission computed tomography and statistical parametric mapping analysis in cirrhotic patients with and without minimal hepatic encephalopathy. Ann Nucl Med 2004 0.79
41 Improvement of regional cerebral blood flow after oral intake of branched-chain amino acids in patients with cirrhosis. World J Gastroenterol 2005 0.79
42 Hepatic arterial infusion of 5-fluorouracil in combination with subcutaneous interferon-alpha for advanced hepatocellular carcinoma. Hepatogastroenterology 2007 0.78
43 Cerebral blood flow in basal ganglia is correlated with clinical signs of hepatic encephalopathy in patients with liver cirrhosis. Am J Gastroenterol 2002 0.78
44 Increased hepatic and renal expressions of multidrug resistance-associated protein 3 in Eisai hyperbilirubinuria rats. J Gastroenterol Hepatol 2004 0.78
45 Modulation of organic anion transporting polypeptide 1 and multidrug resistance protein 3 expression in the liver and kidney of Gunn rats. Hepatol Res 2004 0.78
46 [Severe alcoholic hepatitis resulting in liver transplantation: the first case in Japan]. Nihon Naika Gakkai Zasshi 2005 0.77
47 Iron overload and glucose abnormalities in chronic hepatitis C virus infection: phlebotomy lowers risk of new-onset diabetes. Hepatogastroenterology 2013 0.77
48 Ultrastructural demonstration of hepatitis B virus production in a mouse model produced by hydrodynamic transfection. Int J Mol Med 2007 0.77
49 Positron emission tomography image on evaluating intraperitoneal dissemination of malignant gastrointestinal stromal tumor. Hepatogastroenterology 2008 0.76
50 Expressions of hepatobiliary organic anion transporters and bilirubin-conjugating enzyme in differentiating embryonic stem cells. Biochem Biophys Res Commun 2003 0.76
51 Impaired regulation of serum hepcidin during phlebotomy in patients with chronic hepatitis C. Hepatol Res 2009 0.76
52 Dietary fiber decreases ammonia levels in patients with cirrhosis. Hepatology 2005 0.76
53 Iron content and consumption of health foods by patients with chronic hepatitis C. J Gastroenterol 2006 0.75
54 Different hepatitis C virus dynamics of free-virions and immune-complexes after initiation of interferon-alpha in patients with chronic hepatitis C. J Hepatol 2003 0.75
55 Elevation of 8-isoprostane in patients with hepatitis C virus infection undergoing hemodialysis. J Clin Virol 2006 0.75
56 Immune complex of hepatitis C virus particles detected by immunogold electron microscopy. J Gastroenterol 2006 0.75
57 Retreatment with peginterferon α-2a + ribavirin in patients who failed previous peginterferon α-2b + ribavirin combination therapy. Dig Dis 2012 0.75
58 Transfecting the multidrug resistance protein 2 gene improves transcellular organic anion transport. Int J Mol Med 2005 0.75
59 [Ultrastructural features of the HCV particle and HCV-like particles]. Nihon Rinsho 2004 0.75
60 "Green juice"-associated granulomatous hepatitis. Am J Gastroenterol 2003 0.75
61 Accumulation of 8-nitroguanine in the liver of chronic hepatitis C patients without sustained virological response after completion of interferon therapy. J Gastroenterol 2006 0.75
62 Dubin-Johnson-like black liver with normal bilirubin level. J Gastroenterol 2004 0.75
63 Hepatotoxicity associated with Lyophyllum decastes Sing. (Hatakeshimeji). J Gastroenterol 2006 0.75